A Randomized, Double-Blind, Placebo Controlled Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women With Intertrochanteric Fracture of the Hip.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2009
At a glance
- Drugs ZT 031 (Primary)
- Indications Hip fracture; Osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms SHIFT
- 05 Jun 2009 Actual initiation date (December 2008) added as reported by ClinicalTrials.gov.
- 05 Jun 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 25 Nov 2008 New trial record.